Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
Zeidler HK, Kvien TK, Hannonen P, Wollheim FA, Førre O, Geidel H, Hafström I, Kaltwasser JP, Leirisalo-Repo M, Manger B, et al. Br J Rheumatol. 1998 Aug; 37(8):874-82.